Frontlight ResearchEarly access
Trial site
Jahn Ferenc Del-Pesti Korhaz es Rendelointezet
- 7running trials
- 11closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis5 trials
- Chronic kidney disease3 trials
- Prostate cancer3 trials
- Stroke3 trials
- Asthma1 trial
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- Diabetic eye disease1 trial
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Neuromyelitis optica (NMOSD)1 trial
- and 1 more
- Phase
- Phase 316 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Completed10 trials
- Active, not recruiting7 trials
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche4 trials
- Novo Nordisk A/S3 trials
- Actelion1 trial
- Amgen1 trial
- AstraZeneca1 trial
- and 8 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026